hsv 1 oral treatment sorted by

relevance

, and the Valaciclovir International Study Group 1998 A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections Arch.

Collaborative Famciclovir Genital Herpes Research Group.

.

Oral acyclovir, however, in dosages ranging from 400 to 1,000 mg daily, was effective in reducing by 50 to 78 percent the frequency of herpes labialis following UV light exposure.

HSV-1 is a latent and lifelong virus.

The lesions usually heal within 10 to 14 days.

Acyclovir crosses the placenta and accumulates in breast milk.

80 episodes per patient during placebo treatment and 0.

Primary infection appears two to 20 days after contact with an infected person.

12 orolabial HSV-1 infections, 0.